It is considered by researchers to be one of the most selective secretagogues and is an apparent agonist of the growth hormone/ghrelin secretagogue receptor
Metabolic approaches: GLP-1 Incretins (semaglutide): appetite suppression | GLP-1/GIP incretins (tirzepatide): dual hormonal agonism | 5-Amino-1MQ: NNMT enzyme inhibition a non-hormonal mechanism, directly targeting lipid and NAD+ metabolism
The Clinic Takeaway: What AOD 9604 Means for South Florida Patients AOD 9604 is not a weight loss miracle
We serve patients from Hopewell Junction NY, Stormville NY, Beekman NY, Wappingers Falls NY, Kent NY, Pawling NY, and surrounding areas
Download Product Label Download Product Label Please refer to the registered label for full directions of use
When sourced from a reputable, accredited compounding pharmacy that performs batch potency testing, the effectiveness should be comparable